fda glp-1 warning 2025 november From a new Perspective by Amanda Banks, MD: On February Generic GLP-1 medications: Current and – FDA Issues Warnings Against Illegal

Mol Biol Rep 47:98659882

You'll likely notice increased urination (that's the hydration at work!), and skin brightening effects typically develop over several treatments

17,18 We performed a literature review to assess weight loss outcomes in studies mentioning these classes of medications, including primary results presented by class and adverse side effects

References: Vukojevic J, Milavi M, Perovi D, et al

For patients with IBS-D (diarrhea-predominant), the slowed transit time might theoretically provide some symptomatic benefit by reducing bowel frequency and urgency, though clinical studies specifically examining this relationship in IBS populations are lacking